VAERS reports by lot

Merck HPV lot T028583: VAERS reports

22 VAERS reports list lot T028583 as a Merck HPV vaccine, received between 2021-06-08 and 2023-07-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1128%
Neurological1026%
Gastrointestinal410%
General / Systemic (non-local)410%
Dermatological (non-injection-site)38%
Cardiac / Cardiovascular25%
Reproductive / Menstrual25%
Thrombotic / Hematological13%
Allergic / Anaphylactic13%
Musculoskeletal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Kentucky3
Massachusetts2
California2
Minnesota1
Illinois1
Missouri1
Arizona1
Montana1
Colorado1
Texas1
Oklahoma1

Reports by month received

2021-062
2021-071
2021-082
2021-097
2022-031
2022-041
2022-053
2023-033
2023-041
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.